These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29506828)

  • 21. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous vascularized bone marrow transplantation to promote acceptance of hind limb allografts and its effects on central and peripheral chimerism.
    Kubitskiy A; Li J; Lanzetta M; Owen E; McCaughan GW; Bishop GA
    Transplantation; 2007 May; 83(9):1273-6. PubMed ID: 17496546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.
    Friedman O; Carmel N; Sela M; Abu Jabal A; Inbal A; Ben Hamou M; Krelin Y; Gur E; Shani N
    PLoS One; 2017; 12(7):e0181507. PubMed ID: 28746417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Composite vascularized skin/bone graft model: a viable source for vascularized bone marrow transplantation.
    Siemionow M; Ulusal BG; Ozmen S; Ulusal AE; Ozer K
    Microsurgery; 2004; 24(3):200-6. PubMed ID: 15160378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reciprocal Donor-Recipient Strain Combinations Present Different Vascularized Composite Allotransplantation Outcomes in Rodent Models.
    Cheng HY; Lin CF; Anggelia MR; Lai PC; Shih LY; Liu SC; Wei FC; Lin CH
    Plast Reconstr Surg; 2023 Jun; 151(6):1220-1231. PubMed ID: 36508453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolongation of skin allograft survival after neonatal injection of donor bone marrow and epidermal cells.
    Petit F; Minns AB; Nazzal JA; Hettiaratchy SP; Lantieri LA; Randolph MA; Lee WP
    Plast Reconstr Surg; 2004 Jan; 113(1):270-6. PubMed ID: 14707646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Positive Impact of Donor Bone Marrow Cells Transplantation into Immunoprivileged Compartments on the Survival of Vascularized Skin Allografts.
    Jundziłł A; Klimczak A; Sonmez E; Brzezicki G; Siemionow M
    Arch Immunol Ther Exp (Warsz); 2021 Oct; 69(1):28. PubMed ID: 34633538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance induction following allogeneic vascularized bone marrow transplantation--the possible role of microchimerism.
    Durlik M; Lukomska B; Religa P; Ziolkowska H; Namysłowski A; Janczewska S; Cybulska E; Soin J; Gaciong Z; Olszewski WL
    Transpl Int; 1998; 11 Suppl 1():S299-302. PubMed ID: 9665001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II.
    Klimczak A; Agaoglu G; Carnevale KA; Siemionow M
    Ann Plast Surg; 2006 Oct; 57(4):422-30. PubMed ID: 16998336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascularized bone marrow allotransplantation and low-dose cyclosporine prolong the survival of adipose tissue allografts.
    Hsieh YH; Chen WF; Huang JJ; Wu CW; Engel H; Cheng MH
    Plast Reconstr Surg; 2012 Jul; 130(1):64-72. PubMed ID: 22743874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow.
    Suzuki H; Patel N; Matthews M; DelRossi AJ; Doolin EJ; Hewitt CW
    J Surg Res; 2000 Apr; 89(2):176-83. PubMed ID: 10729247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The intragraft vascularized bone marrow induces secondary donor-specific mystacial pad allograft tolerance.
    Lin CH; Anggelia MR; Cheng HY; Hsieh YH; Chuang WY; Yang HY; Lin CH
    Front Immunol; 2022; 13():1059271. PubMed ID: 36578498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance.
    Kawai T; Poncelet A; Sachs DH; Mauiyyedi S; Boskovic S; Wee SL; Ko DS; Bartholomew A; Kimikawa M; Hong HZ; Abrahamian G; Colvin RB; Cosimi AB
    Transplantation; 1999 Dec; 68(11):1767-75. PubMed ID: 10609955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor modification leads to prolonged survival of limb allografts.
    Lee WP; Butler PE; Randolph MA; Yaremchuk MJ
    Plast Reconstr Surg; 2001 Oct; 108(5):1235-41. PubMed ID: 11604625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tunneled superficial inferior epigastric artery (SIEA) myocutaneous/vascularized femur chimeric flaps: a model to study the role of vascularized bone marrow in composite allografts.
    Mundinger GS; Kelamis JA; Kim SH; Magarakis M; Jones LS; Ha JS; Rodriguez ED
    Microsurgery; 2012 Feb; 32(2):128-35. PubMed ID: 22113953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.
    Chang J; Graves SS; Butts-Miwongtum T; Sale GE; Storb R; Mathes DW
    Transplantation; 2016 Dec; 100(12):e120-e127. PubMed ID: 27861292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The intragraft vascularized bone marrow component plays a critical role in tolerance induction after reconstructive transplantation.
    Lin CH; Anggelia MR; Cheng HY; Wang AYL; Chuang WY; Lin CH; Lee WPA; Wei FC; Brandacher G
    Cell Mol Immunol; 2021 Feb; 18(2):363-373. PubMed ID: 31754236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.